We are live on
!
Find out more
X
Xponance Portfolio holdings
AUM
$16.3B
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter
Est. Return
-3.35%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$5.2B
AUM Growth
+$223M
(+4.5%)
Cap. Flow
+$501M
Cap. Flow
% of AUM
9.63%
Top 10 Holdings %
Top 10 Hldgs %
30.56%
Holding
1,228
New
36
Increased
827
Reduced
326
Closed
36
Avg Time Held
7.5
quarters
Top 10 Avg Time Held
7.1
quarters
Top 20 Avg Time Held
5.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$30.8M |
| 2 |
Microsoft
MSFT
|
+$27.5M |
| 3 |
Amazon
AMZN
|
+$16.1M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$12.9M |
| 5 |
Tesla
TSLA
|
+$12.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlassian
TEAM
|
+$2.99M |
| 2 |
Pinnacle West Capital
PNW
|
+$2.46M |
| 3 |
CTXS
Citrix Systems Inc
CTXS
|
+$1.8M |
| 4 |
Tyson Foods
TSN
|
+$1.69M |
| 5 |
Fifth Third Bancorp
FITB
|
+$1.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.52% |
| 2 | Healthcare | 13.99% |
| 3 | Consumer Discretionary | 13.11% |
| 4 | Financials | 11.18% |
| 5 | Industrials | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1176
Gevo
GEVO
$316M
| $25K | ﹤0.01% |
11,066
+275
| +3% | +$767 |
2022 Q2
1 quarter
|
|
1177
Inovio Pharmaceuticals
INO
$114M
| $24K | ﹤0.01% |
1,151
+162
| +16% | +$4.15K |
2022 Q2
1 quarter
|
|
|
LOGC
1178
DELISTED
ContextLogic
LOGC
| $24K | ﹤0.01% |
1,076
+56
| +5% | +$2.32K |
2022 Q2
1 quarter
|
|
1179
Blend Labs
BLND
$234M
| $23K | ﹤0.01% |
+10,278
| New | +$29.2K |
2022 Q3
0 quarters
|
|
1180
Ocugen
OCGN
$321M
| $21K | ﹤0.01% |
11,978
+452
| +4% | +$1.13K |
2022 Q2
1 quarter
|
|
1181
DELISTED
Core Scientific, Inc. Common Stock
CORZ
| $20K | ﹤0.01% |
15,232
+3,452
| +29% | +$7.34K |
2022 Q2
1 quarter
|
|
1182
Firy Inc
FIRY
$206M
| $18K | ﹤0.01% |
879
+57
| +7% | +$1.61K |
2021 Q2
5 quarters
|
|
1183
DELISTED
Sonder
SOND
| $17K | ﹤0.01% |
+517
| New | +$17.2K |
2022 Q3
0 quarters
|
|
1184
Diversified Healthcare Trust
DHC
$1.85B
| $13K | ﹤0.01% |
13,072
+227
| +2% | +$364 |
2021 Q2
5 quarters
|
|
1185
Ur-Energy
URG
$367M
| $13K | ﹤0.01% |
11,591
+147
| +1% | +$175 |
2022 Q2
1 quarter
|
|
|
BBIG
1186
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
| $12K | ﹤0.01% |
+644
| New | +$12.8K |
2022 Q3
0 quarters
|
|
1187
Cenntro
CENN
$8.62M
| $11K | ﹤0.01% |
+17
| New | +$14.6K |
2022 Q3
0 quarters
|
|
1188
DELISTED
NeueHealth
NEUE
| $11K | ﹤0.01% |
136
+7
| +5% | +$929 |
2022 Q1
2 quarters
|
|
|
VLDR
1189
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $10K | ﹤0.01% |
10,886
+416
| +4% | +$486 |
2022 Q2
1 quarter
|
|
1190
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $8K | ﹤0.01% |
354
+9
| +3% | +$243 |
2022 Q2
1 quarter
|
|
|
BINI
1191
DELISTED
Bollinger Innovations
BINI
| – | – |
0
| – | – |
2022 Q3
0 quarters
|
|
1192
VistaGen Therapeutics
VTGN
$10.1M
| $2K | ﹤0.01% |
355
+3
| +0.9% | +$30 |
2022 Q2
1 quarter
|
|
1193
Asbury Automotive
ABG
$2.94B
| – | – |
-1,377
| Closed | -$233K | – |
|
1194
American Eagle Outfitters
AEO
$3.03B
| – | – |
-24,094
| Closed | -$269K | – |
|
1195
Ally Financial
ALLY
$11.5B
| – | – |
-6,117
| Closed | -$205K | – |
|
1196
American Homes 4 Rent
AMH
$11B
| – | – |
-5,748
| Closed | -$204K | – |
|
1197
Atkore
ATKR
$3.2B
| – | – |
-3,192
| Closed | -$265K | – |
|
1198
Axalta
AXTA
$7.08B
| – | – |
-9,233
| Closed | -$204K | – |
|
1199
Bright Horizons
BFAM
$3.4B
| – | – |
-2,815
| Closed | -$238K | – |
|
1200
Certara
CERT
$1.41B
| – | – |
-9,347
| Closed | -$201K | – |
|
Similar funds
PCM
LPC
MFG
PAM
BS
BBVA
NMO
PAS
Xponance's Q3 2022 Portfolio in Review
As of Q3 2022, Xponance held 1,228 positions worth $5.2B, up 4.5% from $4.98B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Xponance deployed $501M of net new capital in Q3 2022, opening 36 new positions and adding to 827 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 27,780 shares worth $1.22M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Pinnacle West Capital, an estimated $2.46M trimmed.
- Xponance's largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 27,780 shares worth $1.22M.
- Xponance added most to Apple in Q3 2022, an estimated $30.8M increase.
- Xponance's biggest Q3 2022 reduction was Pinnacle West Capital, cutting an estimated $2.46M.
- Xponance fully exited Atlassian in Q3 2022, selling an estimated $2.99M.
- Xponance's ten largest holdings make up 31% of its $5.2B portfolio in Q3 2022.
- Xponance opened 36 new positions and closed 36 in Q3 2022.
- Xponance's portfolio value rose 4.5% quarter-over-quarter to $5.2B.
Based on Xponance's 13F filing for Q3 2022, filed 24 Oct 2022.